Cargando…
An in situ high-throughput screen identifies inhibitors of intracellular Burkholderia pseudomallei with therapeutic efficacy
Burkholderia pseudomallei (Bp) and Burkholderia mallei (Bm) are Tier-1 Select Agents that cause melioidosis and glanders, respectively. These are highly lethal human infections with limited therapeutic options. Intercellular spread is a hallmark of Burkholderia pathogenesis, and its prominent ties t...
Autores principales: | Bulterys, Philip L., Toesca, Isabelle J., Norris, Michael H., Maloy, Jeffrey P., Fitz-Gibbon, Sorel T., France, Bryan, Toffig, Babak, Morselli, Marco, Somprasong, Nawarat, Pellegrini, Matteo, Schweizer, Herbert P., Tuanyok, Apichai, Damoiseaux, Robert, French, Christopher T., Miller, Jeff F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744847/ https://www.ncbi.nlm.nih.gov/pubmed/31439817 http://dx.doi.org/10.1073/pnas.1906388116 |
Ejemplares similares
-
Lipid A Remodeling Is a Pathoadaptive Mechanism That Impacts Lipopolysaccharide Recognition and Intracellular Survival of Burkholderia pseudomallei
por: Norris, Michael H., et al.
Publicado: (2018) -
Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling
por: Norris, Michael H., et al.
Publicado: (2017) -
Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance
por: Chirakul, Sunisa, et al.
Publicado: (2018) -
Evaluation of Delafloxacin against a Burkholderia pseudomallei Efflux Mutant Panel
por: McCurdy, Sandra P., et al.
Publicado: (2022) -
Survival of Burkholderia pseudomallei in Water
por: Moore, Richard A, et al.
Publicado: (2008)